PTGX
Protagonist Therapeutics (PTGX)
$39
About Protagonist Therapeutics (PTGX)
Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.
Details
Daily high
$100.98
Daily low
$97.16
Price at open
--
52 Week High
$105.69
52 Week Low
$39.60
Market cap
6.4B
Dividend yield
0.00%
Volume
83
Avg. volume
937,183
P/E ratio
-49.15
Protagonist Therapeutics News
Details
Daily high
$100.98
Daily low
$97.16
Price at open
--
52 Week High
$105.69
52 Week Low
$39.60
Market cap
6.4B
Dividend yield
0.00%
Volume
83
Avg. volume
937,183
P/E ratio
-49.15